2016
DOI: 10.1084/jem.20160316
|View full text |Cite
|
Sign up to set email alerts
|

Thymic CD4 T cell selection requires attenuation of March8-mediated MHCII turnover in cortical epithelial cells through CD83

Abstract: Work from the Klein lab shows that CD83 supports T cell selection in the thymus by restraining March8-mediated MHCII ubiquitination and internalization.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

2
80
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 67 publications
(82 citation statements)
references
References 30 publications
(50 reference statements)
2
80
0
Order By: Relevance
“…[25][26][27][28][29] Ubiquitin has an ability to control membrane protein expression and localization and exert significant influence on cellular function. Specifically, MARCH1 was shown to be capable of ubiquitinating MHCII and mediating intracellular localization and lysosomal degradation of MHC II in DCs and B cells.…”
Section: Discussionmentioning
confidence: 99%
“…[25][26][27][28][29] Ubiquitin has an ability to control membrane protein expression and localization and exert significant influence on cellular function. Specifically, MARCH1 was shown to be capable of ubiquitinating MHCII and mediating intracellular localization and lysosomal degradation of MHC II in DCs and B cells.…”
Section: Discussionmentioning
confidence: 99%
“…70, 71 CD83 regulates B cell activation and germinal center responses 72 as well as CD4 + T cell development. 73, 74 Although largely expressed by activated APCs, the costimulatory function of CD83 seems to be dispensable for murine T cell activation whilst CD83-stimulated human monocytes suppressed T cell responses. 75, 76 However, the role and function of CD83 in cardiovascular disease is so far unidentified.…”
Section: Co-stimulatory Pathways In Atherosclerosismentioning
confidence: 99%
“…MARCH8(also called c‐MIR and RNF178), a member of the newly discovered MARCH family of (RING) E3 ligases, has been reported to downregulate numerous proteins including major histocompatibility complex (MHC)‐II, CD86, interleukin (IL)‐1 receptor accessory protein, TNF‐related apoptosis‐inducing ligand (TRAIL) receptor 1 and the transferrin receptor (Chen et al, ; Bayer‐Santos et al, ; Sun et al, ; von Rohrscheidt et al, ). The functions of MARCH8 have been mostly studied in immune cells, and MARCH8 has been reported to be dysregulated in human cancers including lung cancer (Fan et al, ) and gastric cancer (Yin et al, ).…”
mentioning
confidence: 99%